Expired Tender Germany ICB TOT Ref. 34680542

Contract notice: Endocrine therapy medicinal Tender - 34680542

Tender notice from Germany, published on 15 Jul 2019.

Executive Summary

The AOK - DIE GESUNDHEITSKASSE FÜR NIEDERSACHSEN has issued a Tender notice for the procurement of a Contract notice: Endocrine therapy medicinal products in the Germany. This Tender notice was published on 15 Jul 2019 and is scheduled to close on 27 Jun 2021, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 34680542, while the tender notice number is 329035-2019 and Register on the platform.

Key facts

Summary
Contract notice: Endocrine therapy medicinal products
TOT Ref. No.
34680542
Document Ref. No.
329035-2019
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
15 Jul 2019
Bid deadline
27 Jun 2021
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Object of the contract
Endocrine therapy medicinal products
Description: Contract notice: Endocrine therapy medicinal products
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: The most economic tender
CPV code: 33652200, 33652200
CPV Description: Endocrine therapy medicinal products.
Conclusion of a non-exclusive discount contract according to - 130a Abs. 8 SGB V on drugs with the active ingredient fulvestrant (ATC code: L02BA03)
Conclusion of a non-exclusive discount agreement according to - 130a Abs. 8 SGB V on medicines with the Active substance Fulvestrant (ATC code: L02BA03) within the period from 1.9.2019 to 31.8.2021 with Moegli at any timeDuring the term of the contract ("open-house model"), the AOK offers the Health Insurance Fund for Lower Saxony for the period until the entry into force of exclusive contracts following a public procurement procedure under the Regulations of the 4th part of the GWB to all interested pharmaceutical companies, without a selection decisionavoidance, discount contracts. The contracts are concluded as part of an "open-house model" and act as a bridge between the start of generic competition (patent expiration) and the awarding of exclusive contracts.The contracts offered are not exclusive, contracts with all market participants (pharmaceutical companies) are part of the AOK Niedersachsen desired. In the openhouse model apply to all participants uniform conditions. Contract contents, conditions and access procedures are uniformly individual negotiations are not conducted in principle. The contract terms are a maximum of twenty-four months, the earliest date of the contract is 1.9.2019. All contracts end no later than 31.8.2021, regardless of the date of the respective Vertragsschlusses. An accession or a contract can be made within the twenty-four month period on the first of each month. There is a right to cancel each 6 weeks to the end of the month. The AOK The health fund for Lower Saxony reserves the right, already during the contract period, the non-exclusive open-house discount contracts by exclusive discount contractsto replace. With the entry into force of exclusive tender agreements, the open-house contracts will be terminated in accordance with the contractual provisions, ie. H. the open-house contracts end automatically. According to the experience of the AOK Niedersachsen, exclusive rebate contracts usually occur 6 to 8 months after the publication of the corresponding tender notice in the Suppinto force of the Official Journal of the European Union. Future contractors in the open-house model are invited to regularly consult the Supplement to the Official Journal of the European Union for these calls for tenders.
Interested pharmaceutical companies may consult the contract documents and conditions under the contact details under I.1)
Contracts relating to the active substance fulvestrant (ATC code: L02BA03) will be concluded for the first time with effect from 1.9.2019. Interested parties wishing to become contract partners on this date must submit the contract documents to be submitted by 28.7.2019 at the address specified in the contract documents. It depends on the access at the AOK Lower Saxony. Later contractsAcquisitions are possible during the twenty-four month maximum maturity on the first of each month. Organizationally, an advance of usually 35 calendar days on the part of the AOK is necessary to the required work, eg. B. the contract message in the Lauer tax (r) to ensure. The exact deadlines are announced with the contract documents. At the voThis publication does not constitute the award of a public service contract within the meaning of the Directive (2014/24 / EU) or the GWB. In order to ensure the widest possible degree of transparency for the intended conclusion of the contract, it will be published in the Supplement to the Official Journal of the European Union. In the absence of an appropriate publication form wThe contract notice will be used. The resulting conceptual requirements, such as the procedure "open procedure", are solely due to the use of this announcement form and the publication platform.Another meaning, in particular a submission to subcontracting regulations, unless they are obligatory for legal reasonsd, is not connected to it.
Internet address (URL): www.aok.de

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The bid deadline for Contract notice: Endocrine therapy medicinal products was 27 Jun 2021. Bidding is closed.

This tender has been issued by AOK - DIE GESUNDHEITSKASSE FÜR NIEDERSACHSEN in Germany.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33652200 - Endocrine therapy medicinal products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 34680542. The purchaser document reference is 329035-2019.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products, Technology and Equipment in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.